Ana-Isabel Fraguas-Sánchez (Ana Isabel Fraguas-Sánchez, Ana I Fraguas-Sánchez)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Pharmaceutics

Cancers

British journal of pharmacology

University of Helsinki

Universidad Complutense de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki

Finland

Postdoctoral Researcher :: Faculty of Sciences

Universidad Francisco de Vitoria

Spain

Associate Professor :: Faculty of Experimental Sciences

Universidad Complutense de Madrid

Spain

PhD Candidate :: Pharmacy and Pharmaceutical Technology

Universidad Complutense de Madrid

Spain

Researcher :: Faculty of Pharmacy

Education History

Universidad Complutense de Madrid

Spain

PHD :: Faculty of Pharmacy

Universidad Complutense de Madrid

Spain

MSC

Publications

Raquel Fernández-García, Francisco Bolás-Fernández, Ana-Isabel Fraguas-Sánchez
Editorial for Special Issue 'Engineering and Characterisation of Novel Nanomedicine Formulations'. Pharmaceutics 16 (5) (2024)
Raquel Fernández-García, Francisco Bolás-Fernández, Ana-Isabel Fraguas-Sánchez
Editorial for Special Issue 'Engineering and Characterisation of Novel Nanomedicine Formulations'. Pharmaceutics 16 (5) (2024)
Mario Alonso-González, Emilia Barcia, Juan-Francisco González, Consuelo Montejo, Luis García-García, Monica-Carolina Villa-Hermosilla, Sofia Negro, Ana-Isabel Fraguas-Sánchez, Ana Fernández-Carballido
Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain. Pharmaceutics 14 (11) (2022)
Ana-Isabel Fraguas-Sánchez, Irene Lozza, Ana Isabel Torres-Suárez
Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 14 (5) (2022)
Cristina Martín-Sabroso, Irene Lozza, Ana Isabel Torres-Suárez, Ana-Isabel Fraguas-Sánchez
Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics 13 (10) (2021)
Cristina Martín-Sabroso, Ana Isabel Torres-Suárez, Mario Alonso-González, Ana Fernández-Carballido, Ana-Isabel Fraguas-Sánchez
Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives. Pharmaceutics 14 (1) (2021)
Ana-Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez, Marie Cohen, Florence Delie, Daniel Bastida-Ruiz, Lucile Yart, Cristina Martín-Sabroso, Ana Fernández-Carballido
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment. Pharmaceutics 12 (5) (2020)
Ana-Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez
Development of Innovative Formulations for Breast Cancer Chemotherapy. Cancers 12 (11) (2020)
Ana-Isabel Fraguas-Sánchez, Cristina Martín-Sabroso, Ana Isabel Torres-Suárez
Insights into the effects of the endocannabinoid system in cancer: a review. British journal of pharmacology 175 (13) (2018)

Ana-Isabel Fraguas-Sánchez.css-eqlu8i{font-size:small;padding-left:4px;} (Ana Isabel Fraguas-Sánchez, Ana I Fraguas-Sánchez)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana-Isabel Fraguas-Sánchez (Ana Isabel Fraguas-Sánchez, Ana I Fraguas-Sánchez)